Although pharmacologic management remains central for treating metabolic syndrome, modifiable behavioral patterns are increasingly important in risk reduction counseling.
How does excess weight influence the risk of lingering neuropsychiatric symptoms after COVID-19? Test your knowledge of the link between body weight and the nervous system’s response to infections.
Test your knowledge on the prevalence of FDA-approved indications for novel cardiovascular-kidney-metabolic therapies and the implications for clinical practice.
With broader availability, adults with prediabetes and even those simply seeking health insights can now track glucose trends in real time—empowering earlier interventions, self-discovery, and more...
At the 2025 AACE Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving use of GLP-1–based therapies beyond diabetes and obesity, highlighting novel indications, ongoing research,...
Obesity guidelines have recently shifted to include a more nuanced and clinically relevant definition of obesity. Do you know what best defines clinical obesity? Take the quiz to test your knowledge!
A 2025 review in the Journal of Clinical Lipidology proposes a North American diagnostic score to help identify familial chylomicronemia syndrome. Can you recognize its key features?
Obesity is associated with an increased risk for cardiovascular disease and other metabolic syndromes. When you treat patients with obesity, during which step of treatment do you suggest weight-loss...
Let us know your thoughts on a Key Action Statement from the American Academy of Pediatrics’ clinical practice guidelines on the evaluation and treatment of children and adolescents with obesity.
